Live Price
Live Volume
Chart Volume 0
Volume 0
5 secCandel Therapeutics Market Segments
Premarket
*No Trades in Segment
Overnight
*No Trades in Segment
After Hours Yesterday
+0.11(+1.41%)
| Open | $7.79 |
|---|---|
| Close | $7.90 |
| Low | $7.79 |
| Low Change | 0.00 (0.00%) |
| High | $7.96 |
| High Change | +0.17 (+2.18%) |
| Range | $0.17 |
| Volume | 80.24K |
| Dollar Volume | $633.90K |
Regular Trading Hours Yesterday
-0.59(-7.04%)
| Open | $8.38 |
|---|---|
| Close | $7.79 |
| Low | $7.70 |
| Low Change | -0.68 (-8.11%) |
| High | $8.44 |
| High Change | +0.06 (+0.72%) |
| Range | $0.74 |
| Volume | 753.917K |
| Dollar Volume | $5.87M |
Premarket Yesterday
+0.00(+0.00%)
| Open | $8.20 |
|---|---|
| Close | $8.20 |
| Low | $8.20 |
| Low Change | 0.00 (0.00%) |
| High | $8.20 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 1K |
| Dollar Volume | $8.20K |
Candel Therapeutics News
1 month agoinvesting.comWhy is Candel Therapeutics stock surging today?
- 1 month agoinvesting.com
Candel Therapeutics stock jumps on BofA upgrade to buy
- 5 months agoinvesting.com
Candel Therapeutics stock falls despite phase 3 trial publication
5 months agobenzinga.comCandel Therapeutics Reports Positive Phase 3 Prostate Cancer Trial Data
- 8 months agoinvesting.com
Candel Therapeutics stock falls on $100 million offering pricing
- 8 months agobenzinga.com
Stock Market Today: Dow Jones, S&P 500 Futures Rise Ahead Of Q4 GDP Numbers—Grail, Candel Therapeutics, Copart In Focus
Candel Therapeutics Top Trades
We are still processing the top long and short trades for today. Please refresh the page in 10 minutes or sign up for Finsuba Premium for real time trade insights.
Candel Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $8.23 |
|---|---|
| 10 Day Moving Average (SMA10) | $8.48 |
| 20 Day Moving Average (SMA20) | $9.29 |
| 50 Day Moving Average (SMA50) | $11.00 |
| 100 Day Moving Average (SMA100) | $10.34 |
| 200 Day Moving Average (SMA200) | $8.23 |
Candel Therapeutics Statistics
| Average Volume (30 Days) | 1.11M |
|---|---|
| P/E Ratio (Current) | -8.57 |
| EPS (Current) | -$1.16 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$57.32M |
| Cash Ratio | 15.89 |
| Current Ratio | 16.09 |
| Quick Ratio | 16.09 |
| Debt to Equity | 0.38 |
| Enterprise Value | $606.86M |
| EV to EBITDA | -8.51 |
| EV to Sales | — |
| Price to Book | 6.03 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | -0.43% |
| Return on Equity | -0.70% |
Candel Therapeutics Stock Splits
There have been no stock splits for Candel Therapeutics (CADL).
Candel Therapeutics Dividends
There have been no dividends for Candel Therapeutics (CADL).